Cascade Prodrug Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $450K
Latest Deal Amount
  • Investors
  • 6

Cascade Prodrug General Information

Description

Developer of chemotherapy intended to treat a variety of solid tumor indications. The company's technology takes advantage of the tumor hypoxia and trigger drug conversion in the tumor where it's needed, thus limiting the exposure of healthy tissue to a potent cytotoxic agent, enabling cancer patients to experience a significantly improved safety profile relative to currently approved chemotherapy agents.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Pharmaceuticals
Primary Office
  • PO BOX 13020
  • Eugene, OR 97440-4300
  • United States
+1 (541) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cascade Prodrug Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 06-Apr-2020 $450K 00.000 Completed Startup
6. Later Stage VC 03-Jun-2016 00000 00.000 Completed Startup
5. Later Stage VC 03-Apr-2015 0000 00.000 Completed Startup
4. Early Stage VC (Series A) 02-Aug-2012 00.000 00.000 000 Completed Startup
3. Grant 11-May-2012 00000 00000 Completed Startup
2. Early Stage VC 14-Feb-2012 $400K $400K Completed Startup
1. Grant 29-Oct-2010 $244K Completed Startup
To view Cascade Prodrug’s complete valuation and funding history, request access »

Cascade Prodrug Executive Team (3)

Name Title Board Seat Contact Info
Allan Cochrane Co-Founder, President, Board Member & Head of Corporate Development
John Nepute Chief Financial Officer
August Sick Co-Founder, Managing Director & Board Member
To view Cascade Prodrug’s complete executive team members history, request access »

Cascade Prodrug Board Members (6)

Name Representing Role Since
Allan Cochrane Cascade Prodrug Co-Founder, President, Board Member & Head of Corporate Development 000 0000
August Sick Cascade Prodrug Co-Founder, Managing Director & Board Member 000 0000
Christopher Schelling Self Board Member 000 0000
Eric Malek Self Board Member 000 0000
Lynnor Stevenson Ph.D Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Cascade Prodrug Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Elevate Capital Venture Capital Minority 000 0000 000000 0
Oregon Nanoscience and Microtechnologies Institute University 000 0000 000000 0
Oregon Venture Fund Venture Capital Minority 000 0000 000000 0
Victor Liu Angel (individual) Minority 000 0000 000000 0
Willamette Angel Conference Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »